University of Cambridge > Talks.cam > Bradford Hill seminars at the Cambridge Institute of Public Health > Valuing the economic benefits of complex interventions: when maximising health is not sufficient

Valuing the economic benefits of complex interventions: when maximising health is not sufficient

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Lucy Lloyd.

BRADFORD HILL SEMINAR: Katherine has an international reputation for the economics of genetic technologies and services

Katherine will be introduced by Dr Hilary Burton, Director of the PHG Foundation. The economic evaluation of complex interventions may be problematic on two levels. The complexity means the intervention may not fit into one of the current appraisal systems and/or maximising health is not the only objective. This presentation discusses the implications of a programme of work that focused on clinical genetics services, as an example of a complex intervention. Genetic services, and tests, are a good example of a complex intervention and have broader objectives than just health gain, which may usefully be measured using the concept related to capability which we have called ‘empowerment’. Further methodological work is required to identify the trade-off between non-health (empowerment) and health benefits for other complex interventions.

This talk is part of the Bradford Hill seminars at the Cambridge Institute of Public Health series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2019 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity